#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14740	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2034	718.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1437	1437	C	847	C,G	792,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14740	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2034	718.7	0	HET	.	.	.	C207T	.	207	207	C	460	460	C	843	C,T	436,335	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27536	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3642	753.9	0	.	n	.	0	T695C	SNP	695	695	T	1042	1042	C	809	C,G	752,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27536	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3642	753.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2318	2318	C	852	C,G	774,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27536	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3642	753.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2392	2392	A	851	A	795	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27536	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3642	753.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2944	2944	C	824	C	777	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27536	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3642	753.9	0	HET	.	.	.	A1638G,C	.	1638	1638	A	1985	1985	A	925	A,G,C	694,157,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1676	folP	855	855	100.0	folP.l15.c4.ctg.1	1507	110.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1038	1040	AGC	170;171;171	A;G;C	154;153;153	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4622	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3316	138.8	1	SNP	p	S91F	1	.	.	271	273	TTC	520	522	TTC	159;160;161	T;T;C	145;144;146	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4622	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3316	138.8	1	SNP	p	G95N	0	.	.	283	285	GGC	532	534	GGC	151;149;151	G;G;C	141;136;138	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4622	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3316	138.8	1	SNP	p	D95G	1	.	.	283	285	GGC	532	534	GGC	151;149;151	G;G;C	141;136;138	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1442	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1377	104.1	1	SNP	p	G45D	0	.	.	133	135	GGC	465	467	GGC	185;186;186	G;G;C	165;165;163	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	738	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	905	80.7	0	.	n	.	0	A197.	DEL	197	197	A	555	555	A	167	A	161	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5706	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2966	191.6	1	SNP	p	D86N	0	.	.	256	258	GAC	611	613	GAC	229;228;230	G;A;C	212;207;213	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5706	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2966	191.6	1	SNP	p	S87R	1	.	.	259	261	CGT	614	616	CGT	232;233;233	C;G;T	214;212;214	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5706	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2966	191.6	1	SNP	p	R87I	0	.	.	259	261	CGT	614	616	CGT	232;233;233	C;G;T	214;212;214	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5706	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2966	191.6	1	SNP	p	R87W	0	.	.	259	261	CGT	614	616	CGT	232;233;233	C;G;T	214;212;214	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5706	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2966	191.6	1	SNP	p	S88P	0	.	.	262	264	TCC	617	619	TCC	231;231;232	T;C;C	213;214;216	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3736	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2589	143.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1529	1531	GGC	213;210;208	G;G,T;C	195;190,1;184	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3602	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2380	150.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1241	1243	GCC	230;229;230	G;C;C	210;210;212	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3602	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2380	150.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1244	1246	ATG	231;226;221	A;T;G	215;211;206	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3602	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2380	150.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1256	1258	ACC	222;221;222	A;C;C	208;211;209	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3602	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2380	150.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1256	1258	ACC	222;221;222	A;C;C	208;211;209	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3602	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2380	150.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1757	1759	ACC	156;154;157	A;C;C	140;144;146	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3602	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2380	150.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1811	1813	GCG	164;165;160	G;C;G	152;151;148	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3602	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2380	150.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1811	1813	GCG	164;165;160	G;C;G	152;151;148	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3602	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2380	150.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1934	1936	GGT	137;139;140	G;G;T,C	131;132;130,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3602	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2380	150.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1943	1945	AGC	139;140;139	A,G;G;C	126,1;129;129	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3602	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2380	150.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1961	1963	CCG	114;117;117	C,G;C,G;G	86,6;88,1;89	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5658	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	2897	194.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1528	1530	CCG	177;175;175	C;C;G	155;161;158	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2248	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1802	124.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	539	539	C	166	C	149	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3100	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1615	190.9	1	SNP	p	G120K	1	.	.	358	360	AAG	640	642	AAG	239;235;235	A;A;G	224;220;219	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3100	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1615	190.9	1	SNP	p	N121D	0	.	.	361	363	AAC	643	645	AAC	236;238;238	A;A;C	220;224;223	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3100	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1615	190.9	1	SNP	p	A121N	1	.	.	361	363	AAC	643	645	AAC	236;238;238	A;A;C	220;224;223	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11872	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4788	247.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1282	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	861	145.5	1	SNP	p	V57M	1	.	.	169	171	ATG	434	436	ATG	258;256;254	A;T;G	238;234;234	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
